Maintaining Perspective: Aligning the Clinical Trial Endpoints With the Needs of the Patient

Time: 3:30 pm
day: Day One


  • How attitudes towards risk-benefit vary between patients, drug developers and regulators
  • Exploring the need to harmonise these viewpoints
  • The importance of presenting patient and caregiver perspectives to the regulators